Organon & Co [NYSE: OGN] plunged by -$0.34 during the normal trading session on Thursday and reaching a high of $10.04 during the day while it closed the day at $9.7.
Organon & Co stock has also loss -3.67% of its value over the past 7 days. However, OGN stock has declined by -24.98% in the 3 months of the year. Over the past six months meanwhile, it has lost -38.76% and lost -56.85% year-on date.
The market cap for OGN stock reached $2.52 billion, with 259.96 million shares outstanding and 259.01 million shares in the current float. Compared to the average trading volume of 5.46M shares, OGN reached a trading volume of 4759014 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Organon & Co [OGN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OGN shares is $13.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OGN stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for Organon & Co shares, keeping their opinion on the stock as In-line, with their previous recommendation back on May 02, 2025. While these analysts kept the previous recommendation, JP Morgan raised their target price from $18 to $20. The new note on the price target was released on September 06, 2024, representing the official price target for Organon & Co stock. Previously, the target price had yet another drop from $33 to $16, while Goldman kept a Neutral rating on OGN stock.
The Price to Book ratio for the last quarter was 4.62, with the Price to Cash per share for the same quarter was set at 2.10. Price to Free Cash Flow for OGN in the course of the last twelve months was 3.25 with Quick ratio for the last quarter at 1.15.
OGN stock trade performance evaluation
Organon & Co [OGN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.67. With this latest performance, OGN shares dropped by -3.48% in over the last four-week period, additionally sinking by -38.76% over the last 6 months – not to mention a drop of -34.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OGN stock in for the last two-week period is set at 46.16, with the RSI for the last a single of trading hit 0.33, and the three-weeks RSI is set at 0.37 for Organon & Co [OGN]. The present Moving Average for the last 50 days of trading for this stock 9.70, while it was recorded at 10.01 for the last single week of trading, and 13.38 for the last 200 days.
Organon & Co [OGN]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Organon & Co [OGN] shares currently have an operating margin of 22.32% and a Gross Margin at 57.18%. Organon & Co’s Net Margin is presently recorded at 11.92%.
Organon & Co (OGN) Capital Structure & Debt Analysis
According to recent financial data for Organon & Co. ( OGN), the Return on Equity (ROE) stands at 254.24%, highlighting impressive shareholder gains. The Return on Assets (ROA) is 5.99%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Organon & Co’s Return on Invested Capital (ROIC) is 7.91%, showcasing its effectiveness in deploying capital for earnings.
Organon & Co (OGN) Efficiency & Liquidity Metrics
Based on Organon & Co’s (OGN) latest financial statements, the Debt-to-Equity Ratio is 16.52%, indicating its reliance on debt financing relative to shareholder equity.
Organon & Co (OGN) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Organon & Co. (OGN) effectively leverages its workforce, generating an average of $75000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.67% and a Quick Ratio of 1.15%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Organon & Co [OGN] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OGN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Organon & Co go to 1.35%.
Organon & Co [OGN]: Institutional Ownership
There are presently around $80.07%, or 80.27%% of OGN stock, in the hands of institutional investors. The top three institutional holders of OGN stocks are: BLACKROCK INC. with ownership of 32.58 million shares, which is approximately 12.6625%. VANGUARD GROUP INC, holding 30.21 million shares of the stock with an approximate value of $$625.41 million in OGN stocks shares; and VANGUARD GROUP INC, currently with $$208.88 million in OGN stock with ownership which is approximately 3.922%.
